Roman Michael F
SEC CIK 1577544 · EDGAR
BoughtSold
Most active insiders at WAY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hawkins Matthew J. | CEO, Dir | — | $5.83M |
| 2 | Sinclair III Eric L. (Ric) | Chief Business Off | — | $2.23M |
| 3 | Schremser Christopher L. | CTO | — | $885.9K |
| 4 | MILLER HEIDI | Dir | $189.0K | — |
| 5 | Miller Melissa F. (Missy) | CMO | — | $125.8K |
| 6 | Khanna Amit | Chief Prod, Tech. Off | — | — |
| 7 | Woods Todd Charles | Chief Commercial Off | — | — |
| 8 | Chan William | Chief Product, AI Off | — | — |
| 9 | Wittman Kimberly S. | CHRO | — | — |
| 10 | Bridge T. Craig | Chief Transformation Off | — | — |
| 16 | Roman Michael F | Dir | — | — |
Transactions 26
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 18:24 | 2026-06-03 | WAY | Waystar Holding Corp. | Roman Michael F | Dir | A - Grant | $0.00 | +9,303 | 14.4K | +181% | $0 | |
| 2026-04-28 19:21 | 2026-04-24 | ABT | Abbott Laboratories | Roman Michael F | Dir | A - Grant | $0.00 | +2,286 | 10.8K | +27% | $0 | |
| 2025-06-16 | 2025-06-16 | WAY | Waystar Holding Corp. | Roman Michael F | Dir | A - Grant | $0.00 | +5,134 | 5,134 | New | $0 | |
| 2025-04-29 | 2025-04-25 | ABT | Abbott Laboratories | Roman Michael F | Dir | A - Grant | $0.00 | +1,635 | 8,478 | +24% | $0 | |
| A | 2025-02-18 | 2025-02-03 | MMM | 3M | Roman Michael F | COB, Dir | F - Tax | $0.00 | -8,600 | 193.4K | -4% | $0 |
| 2025-02-05 | 2025-02-03 | MMM | 3M | Roman Michael F | COB, Dir | A - Grant | $0.00 | +21.0K | 202.0K | +12% | $0 | |
| 2025-02-05 | 2025-02-03 | MMM | 3M | Roman Michael F | COB, Dir | F - Tax | $0.00 | -9,589 | 192.4K | -5% | $0 | |
| DM | 2025-01-30 | 2025-01-29 | MMM | 3M | Roman Michael F | COB, Dir | S - Sale+OE | $152.30 | -49.6K | 189.9K | -21% | -$7.55M |
| D | 2025-01-30 | 2025-01-29 | MMM | 3M | Roman Michael F | COB, Dir | M - OptEx | $130.14 | +54.8K | 230.5K | +31% | +$7.13M |
| D | 2025-01-27 | 2025-01-24 | MMM | 3M | Roman Michael F | COB, Dir | M - OptEx | $146.05 | +45.3K | 221.0K | +26% | +$6.61M |
| DM | 2025-01-27 | 2025-01-24 | MMM | 3M | Roman Michael F | COB, Dir | S - Sale+OE | $150.01 | -45.3K | 186.0K | -20% | -$6.79M |
| M | 2024-08-08 | 2024-08-07 | MMM | 3M | Roman Michael F | COB, Dir | S - Sale | $123.46 | -5,675 | 175.0K | -3% | -$700.6K |
| 2024-04-30 | 2024-04-26 | ABT | Abbott Laboratories | Roman Michael F | Dir | A - Grant | $0.00 | +1,866 | 6,843 | +37% | $0 | |
| A | 2024-02-15 | 2024-02-05 | MMM | 3M | Roman Michael F | COB, CEO, Dir | F - Tax | $0.00 | -791.40 | 157.5K | -0.5% | $0 |
| 2024-02-06 | 2024-02-05 | MMM | 3M | Roman Michael F | COB, CEO, Dir | A - Grant | $0.00 | +25.0K | 158.3K | +19% | $0 | |
| 2024-02-06 | 2024-02-05 | MMM | 3M | Roman Michael F | COB, CEO, Dir | F - Tax | $0.00 | -601 | 157.7K | -0.4% | $0 | |
| 2023-05-02 | 2023-04-28 | ABT | Abbott Laboratories | Roman Michael F | Dir | A - Grant | $0.00 | +1,816 | 4,977 | +57% | $0 | |
| A | 2023-02-21 | 2023-02-06 | MMM | 3M | Roman Michael F | COB, CEO, Dir | F - Tax | $0.00 | -1,140 | 126.8K | -0.9% | $0 |
| D | 2023-02-08 | 2023-02-06 | MMM | 3M | Roman Michael F | COB, CEO, Dir | A - Grant | $0.00 | +35.3K | 128.0K | +38% | $0 |
| D | 2023-02-08 | 2023-02-06 | MMM | 3M | Roman Michael F | COB, CEO, Dir | F - Tax | $0.00 | -844.74 | 127.1K | -0.7% | $0 |
| D | 2022-05-04 | 2022-05-03 | MMM | 3M | Roman Michael F | COB, CEO, Dir | S - Sale+OE | $146.21 | -10.6K | 90.4K | -11% | -$1.55M |
| D | 2022-05-04 | 2022-05-03 | MMM | 3M | Roman Michael F | COB, CEO, Dir | M - OptEx | $101.49 | +10.6K | 101.0K | +12% | +$1.08M |
| 2022-05-03 | 2022-04-29 | ABT | Abbott Laboratories | Roman Michael F | Dir | A - Grant | $0.00 | +1,602 | 3,101 | +107% | $0 | |
| A | 2022-02-22 | 2022-02-07 | MMM | 3M | Roman Michael F | COB, CEO, Dir | F - Tax | $0.00 | -754.04 | 89.6K | -0.8% | $0 |
| D | 2022-02-09 | 2022-02-07 | MMM | 3M | Roman Michael F | COB, CEO, Dir | F - Tax | $0.00 | -558.86 | 89.8K | -0.6% | $0 |
| D | 2022-02-09 | 2022-02-07 | MMM | 3M | Roman Michael F | COB, CEO, Dir | A - Grant | $0.00 | +23.4K | 90.4K | +35% | $0 |
Purchase Sale Sale after option exercise All abbreviations